Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7646 | 1344 | 39.7 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
171 | 3 | MONASCUS//CITRININ//MONASCUS PURPUREUS | 58457 |
43 | 2 | JOURNAL OF LIPID RESEARCH//HDL//LIPOPROTEINS | 30963 |
7646 | 1 | APOLIPOPROTEIN A5//APOLIPOPROTEIN A V//APOLIPOPROTEIN C III | 1344 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | APOLIPOPROTEIN A5 | authKW | 1292394 | 5% | 89% | 64 |
2 | APOLIPOPROTEIN A V | authKW | 1113173 | 4% | 88% | 56 |
3 | APOLIPOPROTEIN C III | authKW | 1091515 | 7% | 52% | 93 |
4 | APOA5 | authKW | 1069707 | 4% | 83% | 57 |
5 | APOLIPOPROTEIN C3 | authKW | 349500 | 1% | 77% | 20 |
6 | APOC3 | authKW | 272605 | 1% | 67% | 18 |
7 | APOC III | authKW | 217775 | 2% | 46% | 21 |
8 | APOA5 GENE | authKW | 181745 | 1% | 100% | 8 |
9 | PREVENT OBES DIABET CARDIOVASC DIS | address | 155771 | 1% | 57% | 12 |
10 | APOLIPOPROTEIN C I | authKW | 148410 | 1% | 47% | 14 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 2956 | 14% | 0% | 192 |
2 | Medical Laboratory Technology | 2250 | 7% | 0% | 94 |
3 | Biochemistry & Molecular Biology | 1807 | 33% | 0% | 440 |
4 | Genetics & Heredity | 1334 | 14% | 0% | 191 |
5 | Cardiac & Cardiovascular System | 1153 | 13% | 0% | 169 |
6 | Nutrition & Dietetics | 977 | 8% | 0% | 103 |
7 | Endocrinology & Metabolism | 763 | 10% | 0% | 138 |
8 | Medicine, Research & Experimental | 427 | 8% | 0% | 104 |
9 | Medicine, General & Internal | 153 | 7% | 0% | 89 |
10 | Biophysics | 120 | 5% | 0% | 61 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PREVENT OBES DIABET CARDIOVASC DIS | 155771 | 1% | 57% | 12 |
2 | LIPID LIPOPROT | 63442 | 1% | 31% | 9 |
3 | ATHEROSCLEROSIS LIPID METAB | 51114 | 0% | 75% | 3 |
4 | MED BIOSCI PHYSIOL CHEM | 40878 | 1% | 20% | 9 |
5 | UNITAT RECERCA LIPIDS ARTERIOSCLEROSI | 36067 | 1% | 18% | 9 |
6 | NUTR GENOM | 31367 | 2% | 7% | 21 |
7 | BIOMED MASS SPECT UNIT | 29206 | 0% | 43% | 3 |
8 | 1 LURGAN AVE | 22718 | 0% | 100% | 1 |
9 | ARTHRIT CLIN RHEUMATOL | 22718 | 0% | 100% | 1 |
10 | ATHEROSCLEROSIS CENET | 22718 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF LIPID RESEARCH | 41678 | 9% | 1% | 125 |
2 | ATHEROSCLEROSIS | 16891 | 7% | 1% | 89 |
3 | LIPIDS IN HEALTH AND DISEASE | 13500 | 2% | 2% | 30 |
4 | JOURNAL OF CLINICAL LIPIDOLOGY | 6823 | 1% | 2% | 14 |
5 | CURRENT OPINION IN LIPIDOLOGY | 4925 | 1% | 1% | 17 |
6 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 4341 | 3% | 1% | 38 |
7 | HUMAN GENETICS | 3443 | 3% | 0% | 35 |
8 | CLINICAL GENETICS | 1934 | 2% | 0% | 21 |
9 | CLINICA CHIMICA ACTA | 1809 | 2% | 0% | 30 |
10 | NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES | 1738 | 1% | 1% | 12 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | APOLIPOPROTEIN A5 | 1292394 | 5% | 89% | 64 | Search APOLIPOPROTEIN+A5 | Search APOLIPOPROTEIN+A5 |
2 | APOLIPOPROTEIN A V | 1113173 | 4% | 88% | 56 | Search APOLIPOPROTEIN+A+V | Search APOLIPOPROTEIN+A+V |
3 | APOLIPOPROTEIN C III | 1091515 | 7% | 52% | 93 | Search APOLIPOPROTEIN+C+III | Search APOLIPOPROTEIN+C+III |
4 | APOA5 | 1069707 | 4% | 83% | 57 | Search APOA5 | Search APOA5 |
5 | APOLIPOPROTEIN C3 | 349500 | 1% | 77% | 20 | Search APOLIPOPROTEIN+C3 | Search APOLIPOPROTEIN+C3 |
6 | APOC3 | 272605 | 1% | 67% | 18 | Search APOC3 | Search APOC3 |
7 | APOC III | 217775 | 2% | 46% | 21 | Search APOC+III | Search APOC+III |
8 | APOA5 GENE | 181745 | 1% | 100% | 8 | Search APOA5+GENE | Search APOA5+GENE |
9 | APOLIPOPROTEIN C I | 148410 | 1% | 47% | 14 | Search APOLIPOPROTEIN+C+I | Search APOLIPOPROTEIN+C+I |
10 | TRIGLYCERIDES | 131018 | 14% | 3% | 192 | Search TRIGLYCERIDES | Search TRIGLYCERIDES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | JONG, MC , HOFKER, MH , HAVEKES, LM , (1999) ROLE OF APOCS IN LIPOPROTEIN METABOLISM - FUNCTIONAL DIFFERENCES BETWEEN APOC1, APOC2, AND APOC3.ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. VOL. 19. ISSUE 3. P. 472-484 | 103 | 72% | 273 |
2 | GARELNABI, M , LOR, K , JIN, J , CHAI, F , SANTANAM, N , (2013) THE PARADOX OF APOA5 MODULATION OF TRIGLYCERIDES: EVIDENCE FROM CLINICAL AND BASIC RESEARCH.CLINICAL BIOCHEMISTRY. VOL. 46. ISSUE 1-2. P. 12-19 | 67 | 93% | 15 |
3 | ZHENG, XY , ZHAO, SP , YAN, H , (2013) THE ROLE OF APOLIPOPROTEIN A5 IN OBESITY AND THE METABOLIC SYNDROME.BIOLOGICAL REVIEWS. VOL. 88. ISSUE 2. P. 490-498 | 76 | 81% | 5 |
4 | NILSSON, SK , HEEREN, J , OLIVECRONA, G , MERKEL, M , (2011) APOLIPOPROTEIN A-V; A POTENT TRIGLYCERIDE REDUCER.ATHEROSCLEROSIS. VOL. 219. ISSUE 1. P. 15 -21 | 65 | 72% | 29 |
5 | SOTOS-PRIETO, M , FRANCES, F , CORELLA, D , (2010) IMPACT OF APOLIPOPROTEIN A5 ON CARDIOVASCULAR RISK. GENETIC AND ENVIRONMENTAL MODULATION.REVISTA MEDICA DE CHILE. VOL. 138. ISSUE 7. P. 868-880 | 53 | 93% | 4 |
6 | KLUGER, M , HEEREN, J , MERKEL, M , (2008) APOPROTEIN A-V: AN IMPORTANT REGULATOR OF TRIGLYCERIDE METABOLISM.JOURNAL OF INHERITED METABOLIC DISEASE. VOL. 31. ISSUE 2. P. 281 -288 | 54 | 93% | 15 |
7 | MERKEL, M , (2008) APA5: AN IMPORTANT REGULATOR OF PLASMA TRIGLYCERIDE LEVELS OR JUST ANTHER APOPROTEIN?.DIABETOLOGIE UND STOFFWECHSEL. VOL. 3. ISSUE 3. P. 153-158 | 56 | 92% | 0 |
8 | NORATA, GD , TSIMIKAS, S , PIRILLO, A , CATAPANO, AL , (2015) APOLIPOPROTEIN C-III: FROM PATHOPHYSIOLOGY TO PHARMACOLOGY.TRENDS IN PHARMACOLOGICAL SCIENCES. VOL. 36. ISSUE 10. P. 675 -687 | 60 | 60% | 11 |
9 | YIN, RX , LI, YY , LAI, CQ , (2011) APOLIPOPROTEIN A1/C3/A5 HAPLOTYPES AND SERUM LIPID LEVELS.LIPIDS IN HEALTH AND DISEASE. VOL. 10. ISSUE . P. - | 53 | 84% | 10 |
10 | XU, CX , BAI, RP , ZHANG, DD , LI, ZL , ZHU, HH , LAI, MD , ZHU, YM , (2013) EFFECTS OF APOA5-1131T > C (RS662799) ON FASTING PLASMA LIPIDS AND RISK OF METABOLIC SYNDROME: EVIDENCE FROM A CASE-CONTROL STUDY IN CHINA AND A META-ANALYSIS.PLOS ONE. VOL. 8. ISSUE 2. P. - | 52 | 79% | 11 |
Classes with closest relation at Level 1 |